| Literature DB >> 29093752 |
Yan Wu1, Yaqiao Hao1,2, Xuan Wei1,2, Qi Shen1, Xuanwei Ding1,3,4,2, Liyan Wang4, Hongxin Zhao1, Yuan Lu3,4.
Abstract
BACKGROUND: Enterobacter aerogenes is a facultative anaerobe and is one of the most widely studied bacterial strains because of its ability to use a variety of substrates, to produce hydrogen at a high rate, and its high growth rate during dark fermentation. However, the rate of hydrogen production has not been optimized. In this present study, three strategies to improve hydrogen production in E. aerogenes, namely the disruption of nuoCDE, overexpression of the small RNA RyhB and of NadE to regulate global anaerobic metabolism, and the redistribution of metabolic flux. The goal of this study was to clarify the effect of nuoCDE, RyhB, and NadE on hydrogen production and how the perturbation of NADH influences the yield of hydrogen gas from E. aerogenes.Entities:
Keywords: Biohydrogen; CRISPR-Cas9; Enterobacter aerogenes; NADH dehydrogenase; Small RNA RyhB
Year: 2017 PMID: 29093752 PMCID: PMC5663082 DOI: 10.1186/s13068-017-0938-2
Source DB: PubMed Journal: Biotechnol Biofuels ISSN: 1754-6834 Impact factor: 6.040
Fig. 1Diagram of primary anaerobic metabolic pathways for bacterial hydrogen production. Shown are three putative strategies to enhance hydrogen yield as outlined in this study. The diagram was adapted from references [8], [17], and [18]
Strains and plasmids used in this study
| Strain or plasmid | Genotype and relevant characteristics | Source or literature |
|---|---|---|
| Strains | ||
| IAM1183 | Wild type | IAM (Tokyo, Japan) |
| IAM1183/N | Carrying plasmid pET-28a-nadE | This study |
| IAM1183/R | Carrying plasmid pKK102-ryhB-cm | This study |
| IAM1183/NR | Carrying plasmid pET-28a-nadE and pKK102-ryhB-cm | This study |
| IAM1183-CD | ∆ | This study |
| IAM1183-CD/N | ∆ | This study |
| IAM1183-CD/R | ∆ | This study |
| IAM1183-CD/RN | ∆ | This study |
| IAM1183-CDE | ∆ | This study |
| IAM1183-CDE/N | ∆ | This study |
| IAM1183-CDE/R | ∆ | This study |
| IAM1183-CD/RN | ∆ | This study |
| |
| TaRaKa |
| |
| TaRaKa |
| | Wild type | This study |
| Plasmid | ||
| pCAS9 |
| [ |
| PTargetF-cat | pMB1 aadA sgRNA-cat | [ |
| PTargetF-nuoN20 | pMB1 aadA sgRNA-nuoN20 | This study |
| pET-28a | N-His, N-Thrombin, N-T7, C-His, Kanr | TaRaKa |
| pSTV28 |
| TaRaKa |
| pMD18-T Vector | TA Cloning vector, | TaRaKa |
| pMD18-T-nadE |
| This study |
| pET-28a-nadE |
| This study |
| pKK102-ryhB | RyhB, | [ |
| pKK102-ryhB-cm | RyhB, | This study |
Primers used in the experiments
| Primers | Oligonucleotide sequence (from 5′ to 3′) | PCR fragment | Source |
|---|---|---|---|
| F-CDuh | CCCTGCAACTTCGGCCTGTCA | Upstream-homologous arm of | This study |
| R-CDuh | TGATTCTCGTGCATTTAAATCTCGTCCGGTGT | This study | |
| F-CDdh | ACCGGACGAGATTTAAATGCACGAGAATCAAC | Downstream-homologous arm of | This study |
| R-CDdh | CTGCTCCAACAGGTCAGGAATCG | This study | |
| F-CDEuh | AGCAAGAAGTCAATAAAAGCGT | Upstream-homologous arm of | This study |
| R-CDEuh | ATCACTGTCTTCATTTAAATCTCGTCCGGTGT | This study | |
| F-CDEdh | CGAGATTTAAATGAAGACAGTGATCCGCA | Downstream-homologous arm of | This study |
| R-CDEdh | ACGGCCTTCAAGGGAGTTAATC | This study | |
| F-nuoCD | TCCTAGGTATAATACTAGTGGCGAACTGCGCAATCGTTTTGGGTTTTAGAGCTAGAAATAGC | nuoCD-N20 | This study |
| R-nuoCD | ACTAGTATTATACCTAGGACTGAGCTAGCTGTCAAG | This study | |
| F-nadE | CCG |
| This study |
| R-nadE | CCC | This study | |
| F-p102-Chol | TGCACG |
| This study |
| R-p102-Chol | CGGCAT | This study |
Relevant restriction enzyme sites are underlined and in italics
Fig. 2Schematic diagram showing the ∆nuoCD and ∆nuoCDE mutants constructed using the CRISPR-Cas9 method
Fig. 3Comparison of cell growth (in terms of OD600) for IAM1183 and its mutants. a Growth curves for IAM1183-CD and IAM1183-CDE. b Growth curves for IAM1183/R, IAM1183-CD/R, and IAM1183CDE/R. c Growth curves for IAM1183/N, IAM1183-CD/N, and IAM1183-CDE/N
Fig. 4Comparison of pH of the medium over time for IAM1183 and its mutants during the 20-h batch cultivation. a The pH curves for IAM1183CD and IAM1183CD. b The pH curves for IAM1183/R, IAM1183-CD/R, and IAM1183-CDE/R. c The pH curves for IAM1183/N, IAM1183-CD/N, and IAM1183-CDE/N
Comparison of the optimal pH for growth between IAM1183 and its mutants at the midpoint of exponential growth and after 20 h of batch cultivation
| Strain | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| IAM1183 | IAM1183/N | IAM1183/R | IAM1183-CD | IAM1183-CD/R | IAM1183-CD/N | IAM1183-CDE | IAM1183-CDE/R | IAM1183-CDE/N | |
| Exponential phase (4-h) | 5.31 ± 0.12 | 5.13 ± 0.07 | 5.61 ± 0.1 | 5.93 ± 0.04 | 5.51 ± 0.16 | 5.45 ± 0.07 | 5.85 ± 0.19 | 5.79 ± 0.11 | 5.82 ± 0.15 |
| Stationary phase (20-h) | 4.65 ± 0.08 | 4.7 ± 0.06 | 4.47 ± 0.14 | 4.72 ± 0.09 | 4.56 ± 0.13 | 4.53 ± 0.12 | 4.54 ± 0.17 | 4.39 ± 0.09 | 4.67 ± 0.08 |
Fig. 5The hydrogen production from glucose compared by IAM1183 among all strains in serum bottle batch assays (n = 3). The yield of H2 generated through the formate pathway can be calculated by the following equation V = V + V − V , where V is the amount of hydrogen produced through the formate pathway, V is the amount of ethanol, V is the amount of acetate, and V is the amount of formate. a Hydrogen evolved from IAM1183-CD and IAM1183-CDE. b Hydrogen evolved from IAM1183/R, IAM1183-CD/R, and IAM1183-CDE/R. c Hydrogen evolved from IAM1183/N, IAM1183-CD/N, and IAM1183-CDE/N. d Special illustration of hydrogen evolved via the NADH pathway
Analysis of consumed substrate and the production of anaerobic metabolites after 20 h of cultivation in a serum bottle for wild-type IAM1183 and mutants (n = 3)
| End product | Strain | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| IAM1183 | IAM1183/R | IAM1183/N | IAM1183-CD | IAM1183-CD/R | IAM1183-CD/N | IAM1183-CDE | IAM1183-CDE/R | IAM1183-CDE/N | |
| Glucose consumed (mM) | 57.42 ± 1.38 | 59.27 ± 0.69 | 60.62 ± 0.85 | 70.02 ± 0.66 | 68.13 ± 0.94 | 74.05 ± 0.43 | 69.02 ± 0.77 | 69.28 ± 0.49 | 71.09 ± 0.39 |
| Residual sugar (mM) | 4.66 ± 0.25 | 4.33 ± 0.12 | 4.09 ± 0.15 | 2,4 ± 0.12 | 2.74 ± 0.17 | 1.67 ± 0.08 | 2.58 ± 0.14 | 2.53 ± 0.09 | 2.2 ± 0.07 |
| 2,3-Butanediol (mM) | 9.35 ± 1.56 | 11.86 ± 0.91 | 11.53 ± 0.78 | 11.73 ± 1.37 | 24.75 ± 0.42 | 13.79 ± 1.09 | 8.26 ± 0.17 | 11.96 ± 0.78 | 10.69 ± 0.26 |
| Lactate (mM) | 23.62 ± 0.46 | 44.15 ± 0.99 | 31.54 ± 0.96 | 18.78 ± 1.03 | 25.33 ± 0.81 | 22.31 ± 0.66 | 32.14 ± 0.29 | 36.61 ± 0.45 | 38.21 ± 0.36 |
| Acetate (mM) | 17.27 ± 0.32 | 10.36 ± 0.39 | 20.31 ± 0.65 | 27.96 ± 0.69 | 23.17 ± 0.55 | 30.52 ± 1.26 | 17.16 ± 0.31 | 15.27 ± 0.13 | 16.01 ± 0.63 |
| Formate (mM) | 2.24 ± 0.17 | 3.92 ± 0.77 | 2.83 ± 0.98 | 6.19 ± 0.76 | 5.98 ± 0.47 | 8.28 ± 1.62 | 3.67 ± 0.34 | 2.92 ± 0.19 | 1.63 ± 0.27 |
| Succinate | 1.86 ± 0.08 | 1.01 ± 0.11 | 2.31 ± 0.19 | 3.22 ± 0.17 | 3.02 ± 0.12 | 3.59 ± 0.36 | 3.79 ± 0.48 | 3.02 ± 0.12 | 3.86 ± 0.23 |
| Ethanol (mM) | 31.93 ± 1.2 | 13.85 ± 2.02 | 38.09 ± 0.98 | 38.69 ± 1.16 | 14.47 ± 1.32 | 40.87 ± 0.72 | 25.14 ± 0.26 | 23.49 ± 1.19 | 29.96 ± 0.77 |
| Citric acid (mM) | 1.68 ± 0.25 | 1.52 ± 0.49 | 1.43 ± 0.33 | 1.69 ± 0.37 | 1.51 ± 0.72 | 1.65 ± 0.96 | 1.57 ± 0.67 | 1.62 ± 0.22 | 1.64 ± 0.93 |
| Acetoin (mM) | 25.71 ± 1.11 | 19.21 ± 0.58 | 27.32 ± 0.64 | 20.99 ± 0.84 | 20.13 ± 0.74 | 25.02 ± 0.17 | 23.19 ± 0.29 | 26.81 ± 0.44 | 25.62 ± 0.51 |
| H2 yield (mol/mol glucose) | 1.47 ± 0.06 | 1.52 ± 0.13 | 1.56 ± 0.17 | 1.83 ± 0.09 | 1.67 ± 0.41 | 1.99 ± 0.22 | 2.14 ± 0.69 | 2.08 ± 0.12 | 2.28 ± 0.12 |
Fig. 6Metabolic distribution of IAM1183 upon overexpression of the small RNA RyhB and NadE after 20 h of cultivation (n = 3). The unit is mole. Redox state balance was calculated as the sum of the products with positive oxidation states and those with negative oxidation states per mole of consumed glucose (W IAM1183, R IAM1183-R, CD/R IAM1183-CD/R, IAM1183-CDE/R, N IAM1183-N, CD/N IAM1183-CD/N, and IAM1183-CDE/N)
Fig. 7Comparison of enzyme activities between the wild-type strain and mutants (n = 3). a Alcohol dehydrogenase (EC 1.1.1.1, ADH). b Lactate dehydrogenase (EC 1.1.1.27, LDH). c 2,3-butanediol dehydrogenase (EC1.1.1.4, BD DH)
Fig. 8Characterization of IAM1183-CDE/N in a 5-L fermenter. a Growth curves. b Change in pH. c H2 evolved during the cultivation between IAM1183-CDE/N and the wild-type strain
Analysis of consumed substrate and anaerobic metabolites after 44 h of cultivation of IAM1183-CDE/N and wild-type IAM1183 in 5-L fermenter
| End product | IAM1183 | IAM1183-CDE/N | Change trend | Percent change (%) |
|---|---|---|---|---|
| Glucose consumption (%) | 79.47 | 97.43 | ↑ | 22.26 |
| Residual sugar (g/L) | 3.08 | 0.33 | ↓ | 87.34 |
| Hydrogen (H2) (L) | 3.110 | 6.060 | ↑ | 94.85 |
| Succinate (mM) | 1.02 | 3.16 | ↑ | 209.8 |
| Lactate (mM) | 24.78 | 26.12 | ↑ | 5.400 |
| Acetate (mM) | 15.33 | 11.47 | ↓ | 25.17 |
| Formate (mM) | 1.260 | 0.790 | ↓ | 37.30 |
| Ethanol (mM) | 10.54 | 12.28 | ↑ | 16.50 |
| Citric acid (mM) | 1.930 | 1.750 | ↓ | 9.330 |
| Acetoin (mM) | 20.73 | 18.58 | ↓ | 10.37 |
| 2,3-Butanediol (mM) | 6.380 | 7.740 | ↑ | 21.31 |